LFCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 94% based on the discounted cash flow analysis.
| Market cap | $178.17 Million |
|---|---|
| Enterprise Value | $313.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.92 |
| Beta | 1.06 |
| Outstanding Shares | 37,477,386 |
| P/E Ratio | -4.63 |
|---|---|
| PEG | -324.27 |
| Price to Sales | 1.54 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.48 |
| Enterprise Value to EBIT | -94.73 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 7.51 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 77.99% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 67.02% |
|---|---|
| Total Invested | $10,931▼ 99.99% |
| Investors Holding | 2▼ 106.00% |
No data
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...